SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 9/01/20 Humana Inc. 8-K:7 9/01/20 10:166K |
Document/Exhibit Description Pages Size 1: 8-K Form 8-K Dated September 1, 2020 HTML 31K 6: R1 Document and Entity Information HTML 45K 8: XML IDEA XML File -- Filing Summary XML 11K 5: XML XBRL Instance -- form8k09012020_htm XML 14K 7: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.LAB XBRL Labels -- hum-20200901_lab XML 63K 4: EX-101.PRE XBRL Presentations -- hum-20200901_pre XML 45K 2: EX-101.SCH XBRL Schema -- hum-20200901 XSD 14K 9: JSON XBRL Instance as JSON Data -- MetaLinks 13± 20K 10: ZIP XBRL Zipped Folder -- 0000049071-20-000117-xbrl Zip 12K
i Delaware
|
i 61-0647538
|
|||||
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
i ☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
i ☐
|
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
i ☐
|
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section
12(b) of the Act:
|
||||
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
i Common Stock
|
i HUM
|
i New York Stock Exchange
|
Item 7.01 |
Regulation FD Disclosure.
|
Diluted earnings per common share
|
FY 2020 Guidance
|
GAAP
|
$23.74 - $24.24
|
Amortization of identifiable intangibles
|
0.51
|
Put/call valuation adjustments associated with the Company’s non-consolidating minority
interest investments
|
.40
|
Change in fair market value of publicly-traded equity securities*
|
($3.05)
|
Receipt of commercial risk corridor receivables previously written off
|
($3.35)
|
Adjusted (non-GAAP) – FY 2020 projected
|
$18.25 to $18.75
|
* Current net unrealized gains associated with investments in publicly-traded equity securities based on the market value of such investments as of August 31, 2020. The future value change of these
investments, their impact on GAAP EPS, and the related non-GAAP adjustment will fluctuate based on the public trading value of the stock. The guidance set forth herein assumes no further change in the fair value of these investments.
|
HUMANA INC.
|
||
BY:
|
|
|
|
||
Senior Vice President, Chief Accounting Officer and Controller
(Principal Accounting Officer)
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
12/31/20 | 10-K, 11-K, 4 | |||
9/30/20 | 10-Q, 4 | |||
Filed on / For Period end: | 9/1/20 | 4 | ||
8/31/20 | ||||
List all Filings |